Therefore, between January 2007 and December 2010 there was an increase of 230.78% in patients with an ischemic cerebrovascular accident who had good lipids control, of 33% in heart failure patients receiving an ACEI (angiotensin-converting-enzyme inhibitor) or ARB (angiotensin receptor blockers) prescription, of 26% in cases of ischemic heart disease receiving proper antiplatelet treatment, and of 21% in infants receiving all recommended vaccinations (Table 2). The gene discussed is ACE; the disease is heart failure.